Advaxis, Inc. Share Price OTC Bulletin Board
Equities
US0076241092
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 692K 54.33M | Sales 2023 | 13K 1.02M | Capitalization | 7.94M 623M |
---|---|---|---|---|---|
Net income 2022 | -38M -2.98B | Net income 2023 | -48M -3.77B | EV / Sales 2022 * | - |
Net cash position 2022 | 657K 51.59M | Net Debt 2023 | 3.43M 270M | EV / Sales 2023 | 875 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 22/04/18 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 15/07/13 |
Roni Appel
CEO | Chief Executive Officer | 57 | 31/10/04 |
Murray Goldberg
BRD | Director/Board Member | 79 | 18/01/23 |
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |